Results of a Phase II trial of gemcitabine, mitoxantrone, and rituximab in relapsed or refractory mantle cell lymphoma
Lawrence E. Garbo, Patrick J. Flynn, Margaret A. MacRae, Mary A. Rauch, Yunfei Wang, Kathryn S. KolibabaVolume:
27
Language:
english
Pages:
6
DOI:
10.1007/s10637-008-9191-7
Date:
October, 2009
File:
PDF, 142 KB
english, 2009